EP0312543A4 - _i(in situ) active compound assembly - Google Patents

_i(in situ) active compound assembly

Info

Publication number
EP0312543A4
EP0312543A4 EP19870905052 EP87905052A EP0312543A4 EP 0312543 A4 EP0312543 A4 EP 0312543A4 EP 19870905052 EP19870905052 EP 19870905052 EP 87905052 A EP87905052 A EP 87905052A EP 0312543 A4 EP0312543 A4 EP 0312543A4
Authority
EP
European Patent Office
Prior art keywords
situ
active compound
compound assembly
assembly
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19870905052
Other versions
EP0312543A1 (en
Inventor
Darryl C. Rideout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Priority to EP94102623A priority Critical patent/EP0603160A3/en
Publication of EP0312543A1 publication Critical patent/EP0312543A1/en
Publication of EP0312543A4 publication Critical patent/EP0312543A4/en
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19870905052 1986-07-03 1987-07-06 _i(in situ) active compound assembly Ceased EP0312543A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP94102623A EP0603160A3 (en) 1986-07-03 1987-07-06 Compositions for in-situ active compound assembly.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88208286A 1986-07-03 1986-07-03
US882082 1986-07-03
US90614386A 1986-09-11 1986-09-11
US906143 1986-09-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP94102623A Division EP0603160A3 (en) 1986-07-03 1987-07-06 Compositions for in-situ active compound assembly.

Publications (2)

Publication Number Publication Date
EP0312543A1 EP0312543A1 (en) 1989-04-26
EP0312543A4 true EP0312543A4 (en) 1990-12-27

Family

ID=27128652

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19870905052 Ceased EP0312543A4 (en) 1986-07-03 1987-07-06 _i(in situ) active compound assembly
EP94102623A Withdrawn EP0603160A3 (en) 1986-07-03 1987-07-06 Compositions for in-situ active compound assembly.

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP94102623A Withdrawn EP0603160A3 (en) 1986-07-03 1987-07-06 Compositions for in-situ active compound assembly.

Country Status (4)

Country Link
EP (2) EP0312543A4 (en)
JP (1) JPH02500023A (en)
AU (1) AU614493B2 (en)
WO (1) WO1988000047A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177083A (en) * 1986-07-03 1993-01-05 The Scripps Clinic And Research Foundation Drugs effective against retroviruses
US6660737B2 (en) 2001-05-04 2003-12-09 The Procter & Gamble Company Medicinal uses of hydrazones
EP2202271A1 (en) 2008-12-29 2010-06-30 Borealis AG Alpha-nucleated polypropylene for power cable insulation
EP2552492A2 (en) 2010-04-02 2013-02-06 Pharmacophotonics, Inc. Single isomeric conjugates of rhodamine dyes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5344622A (en) * 1976-09-30 1978-04-21 Mochida Pharm Co Ltd Immunologically measuring method
US4215102A (en) * 1979-01-05 1980-07-29 Lee Sin H Cytochemical agents and methods for the detection of steroid hormone receptors in human tissues
US4460560A (en) * 1982-06-18 1984-07-17 University Of Southern California Drug delivery by polymeric carriers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SCIENCE, vol. 233, 1986, pages 561-563; D. RIDEOUT: "Self-assembling cytotoxins" *
See also references of WO8800047A1 *
STN FILE SERVER (Karlsruhe) FILE BIOSIS, CHEMICAL ABSTRACTS, vol. 86, abstract no. 450936, Columbus, Ohio, US; D.C. RIDEOUT et al.: "Self assembling cytotoxins", & 192ND AMERICAN CHEMICAL SOCIETY NATIONAL MEETING, ANAHEIM, CALIF., USA, SEPT. 7-12, 1986. ABSTR. PAP. AM. CHEM. SOC. 192 (0). 1986 *

Also Published As

Publication number Publication date
EP0312543A1 (en) 1989-04-26
AU7750387A (en) 1988-01-29
EP0603160A3 (en) 1995-02-22
JPH02500023A (en) 1990-01-11
WO1988000047A1 (en) 1988-01-14
AU614493B2 (en) 1991-09-05
EP0603160A2 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
EG18338A (en) New pharmacologycally active compounds
GB8625185D0 (en) Active compounds
GB8613786D0 (en) Active compounds
GB8409745D0 (en) Active compounds
GB8414987D0 (en) Active compounds
GB8621870D0 (en) Active compounds
PL253413A1 (en) Biologicaly active agent
PH21558A (en) Organochemical compound
EP0312543A4 (en) _i(in situ) active compound assembly
ZA872189B (en) New optically active compound
GB8610911D0 (en) Active compounds
GB8416650D0 (en) Active compound
CS957886A1 (en) Active rc-corrector
GB8610912D0 (en) Active compounds
GB8630635D0 (en) Active compounds
GB8618836D0 (en) Active compounds
GB8613787D0 (en) Active compounds
GB8623768D0 (en) Active compounds
GB8623769D0 (en) Active compounds
GB8603174D0 (en) Active compounds
GB8630629D0 (en) Active compounds
GB8629210D0 (en) Active compounds
GB8629233D0 (en) Active compounds
GB8630626D0 (en) Active compounds
GB8603173D0 (en) Active compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19881228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19901109

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT NL SE

17Q First examination report despatched

Effective date: 19920203

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19940529